New 2026 Symptom-guided approach to central nervous system complications in allogeneic hematopoietic cell transplant recipients: Best practice recommendations from the EBMT Practice Harmonisation and Guidelines committee Group Practice Harmonisation and Guidelines Committee 1st listed author Roser Velasco Journal Bone Marrow Transplant.
New 2026 Impact of donor and recipient EBV serostatus on transplant outcomes in patients with acute leukemia after haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide: Infectious Diseases Working Party EBMT retrospective study Group Infectious Diseases Working Party (IDWP) 1st listed author Jan Styczynski Journal Bone Marrow Transplant.
New 2026 Outcomes of patients over 70 years treated with brexu-cel for R/R mantle cell lymphoma: a study from the CTIWP of EBMT Group Cellular Therapy & Immunobiology Working Party (CTIWP) 1st listed author Nicole Santoro Journal Blood Adv.
New 2026 Long-term outcome of allogeneic hematopoietic cell transplantation for T-cell prolymphocytic leukemia - a study on behalf of the Chronic Malignancies Working Party of the EBMT Group Chronic Malignancies Working Party (CMWP) 1st listed author Joanna Drozd-Sokolowska Journal Haematologica.
New 2026 Outcomes of 544 Patients with t(6;9)/DEK::NUP214 acute myeloid leukemia undergoing allogeneic stem cell transplantation: an EBMT study on behalf of the acute leukemia working party (ALWP) and the pediatric diseases working party (PDWP) Group Acute Leukemia Working Party (ALWP) Paediatric Diseases Working Party (PDWP) 1st listed author Fabio Andreozzi Journal Bone Marrow Transplant.
New 2026 Survey on ICU organization and admission after hematopoietic cell transplantation - a report by IDWP and TCWP of the EBMT Group Infectious Diseases Working Party (IDWP) Complications Working Party (CWP) 1st listed author Joanna Drozd-Sokolowska Journal Bone Marrow Transplant.
New 2026 Defining remission and relapse after allogeneic hematopoietic cell transplantation in myelodysplastic/myeloproliferative neoplasms and optimization of transplantation outcomes: Recommendations from the EBMT practice harmonisation and guidelines committee Group Practice Harmonisation and Guidelines Committee 1st listed author Christopher Armstrong Journal Bone Marrow Transplant.
2026 Management of tyrosine kinase inhibitors and donor lymphocyte infusions post transplantation for chronic myeloid leukemia: a survey of contemporary practice on behalf of the chronic malignancies working party of the EBMT Group Chronic Malignancies Working Party (CMWP) 1st listed author Alexandros Kanellopoulos Journal Bone Marrow Transplant.
2026 Bridging therapy before CAR-T for multiple myeloma: a survey from the CMWP and CTIWP of the EBMT Group Chronic Malignancies Working Party (CMWP) Cellular Therapy & Immunobiology Working Party (CTIWP) 1st listed author Nico Gagelmann Journal Bone Marrow Transplant.
2026 Impact of acute GvHD severity on survival and disease relapse in pediatric patients undergoing allogeneic stem cell transplantation for acute lymphoblastic leukemia: an analysis based on the EBMT-PDWP registry Group Paediatric Diseases Working Party (PDWP) 1st listed author Z Szmit Journal Bone Marrow Transplant.
2026 Peripheral blood stem cells versus bone marrow graft for non-T-depleted haploidentical transplantation with post-transplant cyclophosphamide in patients with secondary acute myeloid leukemia in first complete remission: A study from the ALWP/EBMT Group Acute Leukemia Working Party (ALWP) 1st listed author Arnon Nagler Journal Bone Marrow Transplant.
2026 Incidence and outcome of hemorrhagic cystitis after allogeneic hematopoietic cell transplantation: a survey of the infectious diseases working party of EBMT Group Infectious Diseases Working Party (IDWP) 1st listed author Simone Cesaro Journal Bone Marrow Transplant.